Cargando…
Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer
Breast cancer is the most prevalent malignancy in women. The success of breast cancer treatment relies on the ability to detect the disease and correct molecular abnormalities at an early stage of disease development. A recent article describes a marked decrease in the levels of ferroportin in breas...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096960/ https://www.ncbi.nlm.nih.gov/pubmed/21062518 http://dx.doi.org/10.1186/bcr2641 |